The authors reply: Letter on: "Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy" by Zhou et al.

অনুরূপ উপাদানগুলি

• The authors reply: Letter on: "Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy" by Zhou et al.
  অনুযায়ী: Haiyan Zhou, অন্যান্য
  প্রকাশিত: (2020-10-01)
• Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy
  অনুযায়ী: Zhou, Haiyan, অন্যান্য
  প্রকাশিত: (2020)
• Comment on: “Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy” by Zhou et al.
  অনুযায়ী: Chen, Tai‐Heng
  প্রকাশিত: (2020)
• Antisense Oligonucleotides for the Treatment of Spinal Muscular Atrophy
  অনুযায়ী: Porensky, Paul N., অন্যান্য
  প্রকাশিত: (2013)
• Altered Levels of MicroRNA-9, -206, and -132 in Spinal Muscular Atrophy and Their Response to Antisense Oligonucleotide Therapy
  অনুযায়ী: Catapano, Francesco, অন্যান্য
  প্রকাশিত: (2016)